MegaCHOEP Phase III

Motivation:

The goal of the study was to evaluate the therapeutic efficacy of a high-dose therapy with autologous stem cell therapy.

Description:

Mega-CHOEP phase III is a randomised study comparing conventional chemoimmunotherapy with R-CHOEP-14 with high-dose chemotherapy plus Rituximab with autologous stem cell transplantation in high-risk patients aged 61 to 80 years with Aggressive Non-Hodgkin’s Lymphoma.

Help
help Contributor and Creators
Activity

Views: 26

Created: 20th May 2019 at 11:56

Last updated: 20th May 2019 at 11:56

Related items

Powered by
Seek new full
(v.1.8.3)
Copyright © 2008 - 2019 The University of Manchester and HITS gGmbH
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig